Groove Botanicals, Inc.

What they do

The company states it has not generated any revenue since inception and does not expect revenue from product sales in the near future. It has no products, technologies, or intellectual property rights, and has entered no licensing agreements or formal arrangements with any university, research institution, or technology transfer organization. Its stated plan is to identify and evaluate early-stage intellectual property and applied technologies from Norwegian universities, university hospitals, and applied research institutions for possible licensing or commercialization in North America. Day-to-day operations are managed by its sole officer and director, Kent Rodriguez, with professional services outsourced to third parties.

Revenue drivers

• Net sales — Reported as $0 for both the three months ended June 30, 2026 and June 30, 2025; the company states it has generated no revenue since inception.
• Licensing or commercialization of Norwegian research technologies — Stated intent only — the company has not identified any specific technology and has entered no licensing agreements or formal arrangements with any institution to date.
• Strategic relationships, commercial partnerships, or customer arrangements — Described as possible future structures for commercialization; none exist and no counterparties are named.
• Proposed name change to Nordmark Technologies, Inc. — Intended to describe a corporate focus on Norwegian research-ecosystem technologies; the company states there can be no assurance the name change will be completed.

Recent performance

For the three months ended June 30, 2026, the company reported net sales of $0, unchanged from the three months ended June 30, 2025. It reported a net loss of $21,171 for the June 30, 2026 quarter versus a $38,170 loss a year earlier. Net loss attributable to common stockholders was $75,789 and $92,787 for those same periods, after accrued dividends on Series A and B Preferred stock of $54,618 and $54,617, respectively. Selling, general and administrative expenses were $18,719 in the June 2026 quarter compared with $18,965 a year earlier. At June 30, 2026, total assets were $2,525, total liabilities were $1.5 million, shareholders' equity was negative $1.5 million, and cash and equivalents were $1,494.

Strategy

The company intends to change its name to Nordmark Technologies, Inc. to better describe a focus on early-stage intellectual property and applied technologies originating from Norwegian research ecosystems. It has selected Norway as an initial geographic focus, citing possible relevance of sectors such as energy and offshore technology, maritime and ocean industries, aquaculture, carbon capture, health sciences, medical technology, and other applied industrial and digital technologies. Institutions it may consider reviewing include the University of Oslo, Oslo University Hospital and its associated technology-transfer organization, SINTEF, the Norwegian University of Science and Technology, and the University of Bergen. The company states it has no licensing agreements or formal arrangements with any of these institutions and that no specific technology has been identified.

Risks

• No revenue or commercial operations — The company has generated no revenue since inception and does not expect product revenue in the near future, while reporting a $21,171 net loss for the quarter ended June 30, 2026.
• No assets, IP, or agreements underpinning the stated plan — The company states it has no products, technologies, or intellectual property rights and has entered no licensing agreements or formal arrangements with any university, research institution, or technology transfer organization.
• Minimal cash and negative equity — At June 30, 2026, cash and equivalents were $1,494 and shareholders' equity was negative $1.5 million against total liabilities of $1.5 million, while the company anticipates capital needs of $500,000 to $5,000,000.
• Control concentrated in a single individual — Kent Rodriguez, the sole officer and director, holds 51% of the company's voting rights through Series A Preferred Stock and controls the outcome of all matters submitted to a stockholder vote, including director elections.

Outlook

Management states the company will continue business development and asset acquisition efforts, with anticipated capital needs of between $500,000 and $5,000,000 varying by growth strategy. It intends to pursue a name change to Nordmark Technologies, Inc., and to evaluate early-stage technologies from Norwegian research institutions for possible licensing or commercialization in North America. The company cautions that there can be no assurance suitable technologies will be identified, licensed, developed, or successfully commercialized, and that it does not expect revenue from product sales in the near future.